The AMDP System


Book Description

The 9th edition of this valuable tool for assessing and documenting psychopathology, now in English! Now in its 9th edition, the AMDP System is a widely used tool for documenting psychiatric symptoms in clinical and research projects. It is not only an essential part of many internal clinical documentation systems, but it is also a valuable instrument for training the identification of psychopathological symptoms. This new edition, now in English, involved the complete revision of the psychopathological and somatic symptoms, with particular attention to the elimination of ambiguities and inconsistencies, to the precision of definitions, to the exact differentiation of the self and other ratings, as well as to the user friendliness of the system. Taking account of developments in recent years in the description and rating of psychopathological symptoms, this latest edition of the AMDP System has been extended by an additional eleven psychopathological and three somatic symptoms and a new section on syndrome formation in the appendix. This clearly structured manual enables the standardized application of the system, making it an invaluable tool in the training of medicine and psychology students and an essential reference volume in the psychiatric field.










Senile Dementia of the Alzheimer Type


Book Description

Society is showing increasing concern for disorders related to aging that lead to a loss of brain function. In view of the enormous proportion of elderly people in our society today, brain aging is more than ever subject to challenge to us all, not only politicians and health authorities, but every individual who is confronted with the difficult situation of watching the mental powers of apparently healthy elderly friends, neighbours, or relatives fail, often with alarming rapidity. This challenge is directed especially toward us scientists. As one of our colleagues succinctly put it 2 years ago at the close of our First International Symposium on Brain Aging: "Do something. We are not dealing here with just another disease; we are concerned with human dignity. " More than any statistics, these words convinced me that Tropon's decision to leave the field of classic CNS pharmacology and move into the field of gerontopsychopharmacology was the right one, even though we knew that success would be uncertain and that, even if it finally comes it will be many years hence. At this point, let me add a personal comment: each one of us is judged by his or her own success. We live in a competitive society where success counts. This applies not only to the businessman, but also to the scientist, in particular, to those in industry.







Assessment of Depression


Book Description

Published on Behalf of the World Health Organization




The AGP System


Book Description

Among the more frequently quoted epidemiological facts in current public health discussions are: (a) the elderly today represent about 10% of the population of the industrialized world; (b) the third world nations are moving in the same direction; (c) the trend toward a growing proportion of the aged in the world population will continue over the next few decades; (d) people over 80 now represent the fa. stest growing sector in North America; (e) in the elderly, general morbidity - and particularly morbidity of the central nervous syste- is many times that in the younger popUlation; (f) 5% of those over 65 years of age and 20% of those over 80 suffer from some degree of dementia. A global tidal wave of patients suf fering from Alzheimer's disease (or senile dementia) is threat ening to engulf us by the year 2000. This disease, which is, at our present state of knowledge, ir reversible, and other age-related dementias are perhaps the most sinister forms of any disability. They deprive their vic tims not only of their physical capacities but also of their autonomy and their ability to think and to make decisions for themselves. The future cost of psychogeriatric diseases in terms of suffering for individuals, stress for families, demand for manpower, and budgetary requirements for governments could become astronomical.




Affective and Schizoaffective Disorders


Book Description

Several contributions in our first book about schizo affective disorders (Marneros and Tsuang, Schizoaffective Psychoses, Springer-Verlag, 1986) supported the assumption that schizoaffective disorders differ in relevant ways from schizophrenic disorders. The classification of schizo affective disorders as a subgroup of schizophrenia has also been criticized, and empirical research in clinical, genetic, therapeutic, and prognostic areas supports the idea that there are some strong similari ties between schizo affective and affective disorders. Of course, there are not only similarities between these two groups, but also differences just as there are between schizo affective and schizophrenic disorders. It is precisely the existence of similarities and differences between schizo affective disorders and the other two so-called typical mental disorders, i.e., schizophrenia and affective disorders, which makes them a challenge in psychiatric research, a challenge to the traditional dichotomy in the classification of disorders which originated with Kraepelin. This challenge is certainly proving fruitful in psychiatric research. These "cases in between" may well demonstrate that sep arating, dividing, and limiting is not always meaningful. Sometimes it can be more meaningful to unify; to unify in the sense of building bridges between typical groups. It is here that the assumption of a "psychotic continuum" can become relevant, and the investigation of schizoaffective disorders is of prime importance in research on a possible continuum of psychosis.




Methodology in Evaluation of Psychiatric Treatment


Book Description

First published in 1983, this book is a review of psychiatric treatment by experts in the field from the member countries of the European Medical Research Councils, organized by the European Science Foundation. The volume starts by enumerating the various methods for evaluating psychiatric treatment or evaluating the results of treating specific syndromes, and continues with a chapter on the aims of psychiatric treatment and three on methods of classification of mental diseases. The rest of the book deals with evaluation of treatment, starting with special problems encountered in the difficult areas of evaluation of psychotherapy and social therapeutic methods. There are five chapters on various rating scales and methods and one chapter each on psychophysiological and biochemical criteria in the evaluation of treatment. The last contribution to the book is on ethical and practical problems in theraputic research.




Diagnostics - Classification and Systematics in Psychiatry and Medicine


Book Description

Othmar Maeser, MD, is a specialist in psychiatry and neurology and has been in private practice and as an expert witness in Feldkirch, Austria, for over 27 years. In this book the basic principles of diagnostics, classification and systematics in psychiatry and medicine are presented. This is possible with the help of the philosophy of Immanuel Kant. Through the basis of knowledge, the difference between university medicine and psychiatry as well as that to alternative medicine, complementary medicine and psychosomatics can be made clear. The consequences of the basis of knowledge are presented and discussed for practice and science. Because psychiatry has not paid attention to the basis of its knowledge for several decades, it is in danger of losing its rationally based structure and fragmenting as a science. The book is primarily addressed to physicians, but also to all others who are interested in the fundamentals of knowledge in the field of medical science and other disciplines of healing.